CAPR Competitors & Alternatives
Compare Capricor Therapeutics Inc with similar stocks in the same industry
Biotechnology
CAPR
Main Stock$29.60
Tradestie Score
56
Market Cap
$357.51M
Revenue Growth
-0.1%
Analyst Upside
+82.8%
Top Competitors
229 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
VERA
Vera Therapeutics, Inc. Class A Common Stock
|
$38.20
|
$1.84B | - | 58 | Compare |
|
IMCR
Immunocore Holdings plc American Depositary Shares
|
$29.20
|
$1.81B | - | 64 | Compare |
|
ABCL
AbCellera Biologics Inc. Common Shares
|
$5.63
|
$1.78B | - | 56 | Compare |
|
DYN
Dyne Therapeutics, Inc. Common Stock
|
$20.26
|
$1.78B | - | 62 | Compare |
|
VRDN
Viridian Therapeutics, Inc. Common Stock
|
$17.28
|
$1.74B | - | 61 | Compare |
|
CLDX
Celldex Therapeutics, Inc
|
$32.98
|
$1.68B | - | 56 | Compare |
|
MNKD
Mannkind Corporation
|
$3.93
|
$1.65B | - | 64 | Compare |
|
EWTX
Edgewise Therapeutics, Inc. Common Stock
|
$38.83
|
$1.63B | - | 67 | Compare |
|
BHVN
Biohaven Ltd.
|
$14.78
|
$1.57B | - | 61 | Compare |
|
VCEL
Vericel Corporation
|
$40.39
|
$1.56B | 94.1 | 57 | Compare |
More CAPR Analysis
Data updated: Jun 24, 2026 | Industry: Biotechnology (SIC 2834)
229 stocks in this industry